HIGH GRADE NEUROENDOCRINE CARCINOMA/SMALL CELL CARCINOMA

Clinical trials for HIGH GRADE NEUROENDOCRINE CARCINOMA/SMALL CELL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new HIGH GRADE NEUROENDOCRINE CARCINOMA/SMALL CELL CARCINOMA trials appear

Sign up with your email to follow new studies for HIGH GRADE NEUROENDOCRINE CARCINOMA/SMALL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

New hope for rare cancers: Two-Drug combo enters key trial

Disease control Ongoing

This study is testing whether a combination of two immunotherapy drugs, nivolumab and ipilimumab, can help control advanced, rare cancers of the urinary and reproductive systems. It is for adults whose cancer has spread and who have few other treatment options. The main goal is t…

Matched conditions: HIGH GRADE NEUROENDOCRINE CARCINOMA/SMALL CELL CARCINOMA

Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

HIGH GRADE NEUROENDOCRINE CARCINOMA/SMALL CELL CARCINOMA

Get alerted when new HIGH GRADE NEUROENDOCRINE CARCINOMA/SMALL CELL CARCINOMA trials appear

New hope for rare cancers: Two-Drug combo enters key trial